Healthy Population Clinical Trial
Official title:
A Randomized Controlled Trial of Time-restricted Diet Combined With Multimodal Aerobic Exercise Intervention on Cardiovascular and Metabolic Health in a Sedentary Population
Verified date | April 2023 |
Source | Peking University |
Contact | Tao Huang, Dr |
Phone | 13488745828 |
huangtao[@]bjmu.edu.cn | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Objective: This study aims to compare the effects of a combination of time-restricted diet and multimodal aerobic exercise (calisthenics, yoga, and comprehensive physical training) on cardiovascular and metabolic health in a sedentary population with both interventions alone. Study design. Randomized controlled trial Participants: Sedentary (average sitting time greater than 6 hours per day over the past six months, and average moderate-intensity physical activity less than 125 minutes per week or vigorous-intensity physical activity less than 75 minutes per week as assessed by the International Physical Activity Questionnaire). Sample size: 81 Study grouping and intervention measures: Subjects who signed informed consent and met the inclusion/exclusion conditions were randomly divided into the following three groups according to gender stratification, with 27 participants in each group: single time-limited diet group, single multi-mode aerobic exercise (aerobics, yoga and comprehensive physical training) group, and combination of time-limited diet and multi-mode aerobic exercise group. The subjects who received the time-restricted diet intervention were allowed to eat only from 7am to 3pm on Tuesdays, Thursdays and Saturdays, and were allowed to drink pure water only during the rest of the day. The subjects who received the multi-mode aerobic exercise intervention carried out the exercise intervention from 6:00 PM to 7:00 PM on Monday, Wednesday and Friday under the unified guidance of the physical education teacher of the Medical Department. All subjects did not limit their total daily energy intake. The intervention lasted eight weeks. Outcome evaluation indicators: The main indicators of this study were body composition (body fat, muscle mass, fat-free weight, body weight, BMI, body fat percentage, total body water, protein, inorganic salts, limb muscle and extracellular water ratio).
Status | Not yet recruiting |
Enrollment | 81 |
Est. completion date | October 20, 2023 |
Est. primary completion date | September 20, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: 1. In the past six months, the average daily sitting time was more than 6 hours, and the average weekly moderate-intensity physical activity time was less than 125 minutes or high-intensity physical activity time was less than 75 minutes as assessed by the International Physical Activity Questionnaire (JAMA Intern Med. 2022 Jun 1; 182(6):650-659, J Sport Health Sci. 2022 Mar; 11(2): 164 -- 171. And Global recommendations on physical activity for health); 2. BMI of 18.5-30 kg/m 2, age 18-50, where BMI= weight (kg)/height 2 (m); 3. Weight change less than 3 kg in the last six months; 4. Unlimited hours or other types of fasting, such as alternate-day fasting or simulated fasting diets; 5. No cardiovascular metabolic diseases such as hypertension, type 2 diabetes, chronic kidney disease, coronary heart disease and stroke; 6. No movement disorder related diseases, no sports injury history in the past six months. Exclusion Criteria: 1. Weigh more than 100 kg; 2. Used weight-loss drugs or dietary supplements and used hormone drugs in the past six months; 3. Abnormal liver and kidney function was found by laboratory examination; 4. Women who are pregnant, lactating or planning to become pregnant in the near future; 5. Still unable to skillfully use smart phones and sports bracelets after training; 6. Other circumstances deemed unsuitable for participation in the study by the researchers |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Peking University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body fat | Measurements were made using the Inbody 770, using the bioresistive method | Baseline survey | |
Primary | Muscle mass | Measurements were made using the Inbody 770, using the bioresistive method | Baseline survey | |
Primary | Fat-free weight | Measurements were made using the Inbody 770, using the bioresistive method | Baseline survey | |
Primary | body weight | Measurements were made using the Inbody 770, using the bioresistive method in Kg | Baseline survey | |
Primary | body weight | Measurements were made using the Inbody 770, using the bioresistive method in Kg | 8 weeks after baseline survey | |
Primary | Body fat percentage | Measurements were made using the Inbody 770, using the bioresistive method in % | Baseline survey | |
Primary | Body fat percentage | Measurements were made using the Inbody 770, using the bioresistive method in % | 8 weeks after baseline survey | |
Primary | Body water | Measurements were made using the Inbody 770, using the bioresistive method | Baseline survey | |
Primary | Body water | Measurements were made using the Inbody 770, using the bioresistive method | 8 weeks after baseline survey | |
Primary | Muscle mass | Measurements were made using the Inbody 770, using the bioresistive method | 8 weeks after baseline survey | |
Primary | Body fat | Measurements were made using the Inbody 770, using the bioresistive method | 8 weeks after baseline survey | |
Primary | Fat-free weight | Measurements were made using the Inbody 770, using the bioresistive method | 8 weeks after baseline survey | |
Primary | Body mass index | Measurements were made using the Inbody 770, measured by weight(Kg) divided by height(meter) squared | Baseline survey | |
Primary | Body mass index | Measurements were made using the Inbody 770, measured by weight(Kg) divided by height(meter) squared | 8 weeks after baseline survey | |
Secondary | Waist circumference | The measurements are made by a professional using a tape measure | Baseline survey | |
Secondary | Waist circumference | The measurements are made by a professional using a tape measure | 8 weeks after baseline survey | |
Secondary | Hip circumference | The measurements are made by a professional using a tape measure | Baseline survey | |
Secondary | Hip circumference | The measurements are made by a professional using a tape measure | 8 weeks after baseline survey | |
Secondary | Blood pressure | The measurement was carried out using an electronic sphygmomanometer, and the average value was measured three times in the resting state | Baseline survey | |
Secondary | Blood pressure | The measurement was carried out using an electronic sphygmomanometer, and the average value was measured three times in the resting state | 8 weeks after baseline survey | |
Secondary | Heart rate | The heart rate band was used for measurement, and the resting state was measured three times to take the average value | Baseline survey | |
Secondary | Heart rate | The heart rate band was used for measurement, and the resting state was measured three times to take the average value | 8 weeks after baseline survey | |
Secondary | Blood Lipid | Fasting blood lipid (TC, TG, HDL-C, LDL-C),Blood is drawn by a trained nurse and blood biochemical tests are performed | Baseline survey | |
Secondary | Blood Lipid | Including TC, TG, HDL-C, LDL-C ,blood is drawn by a trained nurse and blood biochemical tests are performed | 8 weeks after baseline survey | |
Secondary | urine routine | Including urinary protein, urinary creatinine, urine collection was followed by routine urine testing at the hospital | Baseline survey | |
Secondary | urine routine | Including urinary protein, urinary creatinine, urine collection was followed by routine urine testing at the hospital | 8 weeks after baseline survey | |
Secondary | Questionnaire survey | Demographic characteristics questionnaire, 4-day 24-hour dietary review, international physical activity questionnaire, sleep quality questionnaire, CNAQ appetite questionnaire | Baseline survey | |
Secondary | Questionnaire survey | Demographic characteristics questionnaire, 4-day 24-hour dietary review, international physical activity questionnaire, sleep quality questionnaire, CNAQ appetite questionnaire | 8 weeks after baseline survey |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05534477 -
Verily Clinical Study Watch Analytical Validation Study
|
||
Active, not recruiting |
NCT06314659 -
Immunogenicity and Safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in Volunteers Aged 3-5 Months
|
Phase 3 | |
Not yet recruiting |
NCT05827198 -
Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Candies
|
N/A | |
Completed |
NCT05794100 -
Evaluating the Impact of Different Sugar Replacer Combinations on Gastrointestinal Tolerance
|
N/A | |
Completed |
NCT03797599 -
Study Examining the Effects of Mindfulness and Similar Audio-guided Exercises.
|
N/A | |
Recruiting |
NCT05323032 -
Multifocal Electroretinogram in Normal Egyptian Population
|
N/A | |
Completed |
NCT03509818 -
Effects of the Physical Fitness on Serum Klotho Levels in Healthy Population
|
N/A | |
Active, not recruiting |
NCT05339841 -
Italian Digital Primary Cardiovascular Prevention Study
|
N/A | |
Completed |
NCT05193799 -
Evaluation of the Tolerance of Three Masks Under Dermatological Control.
|
N/A | |
Completed |
NCT03067532 -
Assessment of Educational Effect of Home-made Robotic Surgery Simulator for Novice Robotic Surgeons
|
N/A | |
Completed |
NCT04582994 -
The Role of Beta Oscillation in Mental Time Travel
|
||
Active, not recruiting |
NCT05999916 -
Evaluate the Safety and Feasibility of tACS With the Miamind Neurostimulator in Healthy Participants
|
N/A | |
Active, not recruiting |
NCT06314685 -
Immunogenicity and Safety of MCV4 in Volunteers Aged 6 Months-5 Years
|
Phase 3 | |
Completed |
NCT04904133 -
Effects of Low/No Calorie Sweeteners on Glucose Tolerance
|
N/A |